https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-20", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-20T12:31:19.34Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-11-10", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Bowel Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department takes to monitor adherence to waiting-time standards for suspected bowel cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4530", "label" : {"_value" : "Biography information for Michelle Donelan"}
}
, "tablingMemberConstituency" : {"_value" : "Chippenham"}
, "tablingMemberPrinted" : [{"_value" : "Michelle Donelan"}
], "uin" : "112383"}
, {"_about" : "http://data.parliament.uk/resources/786224", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/786224/answer", "answerText" : {"_value" : "Testing for Lynch syndrome in people with colorectal cancer is targeted using criteria based on family history and age of cancer onset to determine those at highest risk. The National Institute for Health and Care Excellence guidance recommends extending this offer to all people with colorectal cancer when they are first diagnosed.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-14", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-14T12:07:47.8Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-11-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Bowel Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to improve the identification and management of Lynch syndrome.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4530", "label" : {"_value" : "Biography information for Michelle Donelan"}
}
, "tablingMemberConstituency" : {"_value" : "Chippenham"}
, "tablingMemberPrinted" : [{"_value" : "Michelle Donelan"}
], "uin" : "111889"}
, {"_about" : "http://data.parliament.uk/resources/786225", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/786225/answer", "answerText" : {"_value" : "
Public Health England\u2019s (PHE) Be Clear on Cancer campaigns raise the public\u2019s awareness of signs and symptoms of cancer, and are an important step in diagnosing cancers earlier. The Be Clear on Cancer Abdominal Symptoms pilot campaign aimed to raise awareness of a range of abdominal symptoms that can indicate a number of cancers, including bowel, and encouraged people to visit their doctor promptly. The first pilot ran earlier this year in the East and West Midlands and PHE is working with NHS England on timings and location for the second pilot phase.<\/p>
<\/p>
Earlier this year, PHE also collaborated with Cancer Research UK to deliver a pilot Be Clear on Cancer campaign in the North West of England to promote uptake of bowel screening; the campaign is currently being evaluated to assess its impact on uptake.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-14", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-14T12:13:24.65Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-11-07", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Bowel Cancer"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to promote awareness and early diagnosis of bowel cancer.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4530", "label" : {"_value" : "Biography information for Michelle Donelan"}
}
, "tablingMemberConstituency" : {"_value" : "Chippenham"}
, "tablingMemberPrinted" : [{"_value" : "Michelle Donelan"}
], "uin" : "111891"}
, {"_about" : "http://data.parliament.uk/resources/777820", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/777820/answer", "answerText" : {"_value" : "
The Department funds research into all aspects of human health, including cancer, through the National Institute for Health Research (NIHR) at the level of £1 billion per year. NIHR cancer research expenditure has risen from £101 million in 2010/11 to £137 million in 2016/17.<\/p>
<\/p>
As with other Government funders of health research, the NIHR does not allocate funding for specific disease areas. The level of research spend in a particular area, such as cervical cancer, is driven by factors including scientific potential and the number and scale of successful funding applications.<\/p>
<\/p>
Nineteen major funders of cancer research in the United Kingdom work together as the National Cancer Research Institute (NCRI). These funders include the Department, the Medical Research Council and Cancer Research UK. Through coordinating their research, NCRI partners maximise the impact of research for cancer patients and the public.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "dateOfAnswer" : {"_value" : "2017-11-03", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-03T11:24:21.57Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cervical Cancer: Research"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of trends in the level of funding for research on cervical cancer in the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4530", "label" : {"_value" : "Biography information for Michelle Donelan"}
}
, "tablingMemberConstituency" : {"_value" : "Chippenham"}
, "tablingMemberPrinted" : [{"_value" : "Michelle Donelan"}
], "uin" : "109666"}
, {"_about" : "http://data.parliament.uk/resources/777826", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/777826/answer", "answerText" : {"_value" : "
A range of work is being undertaken by Public Health England (PHE) to understand the reasons for the decline in uptake and to support the National Health Service and local authorities to address them. They include access to timely and useful data for benchmarking, evidence on best practices to increase uptake among women who wish to be screened, using governance levers to advice NHS and local authorities and working in partnership with commissioners, providers and charities.<\/p>
<\/p>
NHS England closely monitors the coverage rates for cervical screening in all age groups. Local NHS England commissioners analyse coverage rates within their area and work with general practices to improve coverage by sharing best practice. Work done to increase uptake includes sharing and implementing best practice such as cervical screening guides for general practitioner (GP) practices or targeting practices with low coverage rates, where relevant this includes working to retain delivery via the genitourinary medicine clinics, further roll out of GP-endorsed text reminder services, and supporting non NHS England research project for self-testing pilot for cervical screening.<\/p>
<\/p>
At a national level, NHS England is working with PHE to make evidence-based improvements such as improving invitation letters to patients to encourage more to attend their cervical screening appointment.<\/p>
<\/p>
NHS England is working in partnership with Cancer Research UK and Macmillan Cancer Support on the Accelerate, Coordinate, Evaluate (ACE) Programme aiming to generate knowledge about effective approaches to achieve earlier diagnosis. A number of ACE test sites are evaluating approaches to increase screening rates in a range of groups, including black and ethnic minority women, women with learning disabilities and women from disadvantaged backgrounds.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "109729"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-02T12:01:51.627Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cervical Cancer: Screening"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to address the downward trend in cervical cancer screening rates among women.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4530", "label" : {"_value" : "Biography information for Michelle Donelan"}
}
, "tablingMemberConstituency" : {"_value" : "Chippenham"}
, "tablingMemberPrinted" : [{"_value" : "Michelle Donelan"}
], "uin" : "109728"}
, {"_about" : "http://data.parliament.uk/resources/777827", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/777827/answer", "answerText" : {"_value" : "
A range of work is being undertaken by Public Health England (PHE) to understand the reasons for the decline in uptake and to support the National Health Service and local authorities to address them. They include access to timely and useful data for benchmarking, evidence on best practices to increase uptake among women who wish to be screened, using governance levers to advice NHS and local authorities and working in partnership with commissioners, providers and charities.<\/p>
<\/p>
NHS England closely monitors the coverage rates for cervical screening in all age groups. Local NHS England commissioners analyse coverage rates within their area and work with general practices to improve coverage by sharing best practice. Work done to increase uptake includes sharing and implementing best practice such as cervical screening guides for general practitioner (GP) practices or targeting practices with low coverage rates, where relevant this includes working to retain delivery via the genitourinary medicine clinics, further roll out of GP-endorsed text reminder services, and supporting non NHS England research project for self-testing pilot for cervical screening.<\/p>
<\/p>
At a national level, NHS England is working with PHE to make evidence-based improvements such as improving invitation letters to patients to encourage more to attend their cervical screening appointment.<\/p>
<\/p>
NHS England is working in partnership with Cancer Research UK and Macmillan Cancer Support on the Accelerate, Coordinate, Evaluate (ACE) Programme aiming to generate knowledge about effective approaches to achieve earlier diagnosis. A number of ACE test sites are evaluating approaches to increase screening rates in a range of groups, including black and ethnic minority women, women with learning disabilities and women from disadvantaged backgrounds.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-11-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "109728"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-02T12:01:51.69Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-10-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cervical Cancer: Screening"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what steps his Department is taking to increase cervical cancer screening uptakes among women in the 25 to 29 age group.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4530", "label" : {"_value" : "Biography information for Michelle Donelan"}
}
, "tablingMemberConstituency" : {"_value" : "Chippenham"}
, "tablingMemberPrinted" : [{"_value" : "Michelle Donelan"}
], "uin" : "109729"}
, {"_about" : "http://data.parliament.uk/resources/758215", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/758215/answer", "answerText" : {"_value" : "
The National Institute for Health and Care Excellence is the independent, expert body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources. The methods and processes it uses in the development of its guidance are internationally respected and have been developed through extensive engagement with a full range of stakeholders, including the Department, and are periodically reviewed to ensure that they remain fit for purpose.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-09-14", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-09-14T14:12:16.797Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-09-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Rare Diseases: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the NICE process for reviewing new treatments for rare diseases.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4530", "label" : {"_value" : "Biography information for Michelle Donelan"}
}
, "tablingMemberConstituency" : {"_value" : "Chippenham"}
, "tablingMemberPrinted" : [{"_value" : "Michelle Donelan"}
], "uin" : "9043"}
, {"_about" : "http://data.parliament.uk/resources/756713", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/756713/answer", "answerText" : {"_value" : "
Government policy is that exposures to electromagnetic fields from mobile phone masts and other radio-transmitting equipment should comply with the guidelines on limiting exposure from the International Commission on Non-Ionizing Radiation Protection (ICNIRP). This policy is reflected in the National Planning Policy Framework for England, which contains provisions in respect of ICNIRP compliance.<\/p>
<\/p>
The former Health Protection Agency published a comprehensive review of the evidence prepared by its independent Advisory Group on Non-ionising Radiation (AGNIR) in 2012. The Group\u2019s overall conclusion was that although a substantial amount of research has been conducted in this area, there is no convincing evidence that electromagnetic field exposures below guideline levels cause health effects in either adults or children.<\/p>
<\/p>
Included within the AGNIR report are many measurements that have been published showing that exposures of the general public living near to mobile phone masts are well within the ICNIRP levels.<\/p>
<\/p>
Public Health England has committed to keeping emerging evidence under review and preparing another comprehensive review when sufficient new evidence has accumulated.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2017-09-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-09-12T16:27:50.683Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-09-04", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Mobile Phones: Aerials"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, whether he plans to review the acceptable levels of exposure to radiofrequency radiation from mobile telephone base stations.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4530", "label" : {"_value" : "Biography information for Michelle Donelan"}
}
, "tablingMemberConstituency" : {"_value" : "Chippenham"}
, "tablingMemberPrinted" : [{"_value" : "Michelle Donelan"}
], "uin" : "8421"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&AnsweringBody.=Department+of+Health&tablingMemberConstituency=Chippenham", "page" : 0, "startIndex" : 1, "totalResults" : 36, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}